LifeStance Health Group, Inc.(LFST)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

LifeStance Health Group, Inc. (LFST) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores LFST at 63.4/100 on a 32-signal composite quality model, placing it at rank #633 of 2,960 stocks — the top 25% of the AI-ranked universe. LFST scores in the top quartile across earnings quality (93.7), revenue growth (77.3). Shareholder dilution risk is elevated at 24.2/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), LifeStance Health Group, Inc. reports quarterly revenue of $435.4M, net income of $23.6M, an operating margin of 7.0%. Top institutional holders of LFST by reported 13-F value include TPG GP A, FMR, BlackRock, based on the most recent SEC filings. LFST trades on the Nasdaq exchange and files with the SEC under CIK 1845257. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate LFST daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for LifeStance Health Group, Inc. directly from SEC EDGAR.